Takeda Pharmaceutical (TAK) Operating Income (2017 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Operating Income of $1.3 billion for Q2 2026, down 0.93% year-over-year from $1.3 billion in Q2 2025, and down 1.6% quarter-over-quarter from $1.3 billion in Q1 2026.
Takeda Pharmaceutical (TAK) Operating Income (2017 - 2026) Analysis & Trends
Takeda Pharmaceutical's Operating Income history runs 10 years deep, the most recent figure standing at $1.3 billion for Q2 2026.
- In Q2 2026, Operating Income fell 0.93% year-over-year to $1.3 billion; the TTM figure through Jun 2026 stood at $2.7 billion (down 43.44% YoY), while the FY2026 annual figure was $41.3 million, down 98.16% from the prior year.
- Operating Income for Q2 2026 stood at $1.3 billion, down from $1.3 billion in the prior quarter.
- The five-year high for Operating Income was $2.9 billion in Q3 2025, with the low at -$2.7 billion in Q4 2025.
- The 5-year median for Operating Income is $1.2 billion (2025), against an average of $1.1 billion.
- The sharpest annual moves came in 2023 and 2025: Operating Income jumped 268.02% in 2023, then slumped 448.93% in 2025.
- Takeda Pharmaceutical's Operating Income stood at $1.0 billion in 2022, then slumped by 42.39% to $599.4 million in 2023, then plunged by 182.19% to -$492.7 million in 2024, then plunged by 448.93% to -$2.7 billion in 2025, then soared by 146.73% to $1.3 billion in 2026.
- Business Quant data shows TAK's Operating Income at $1.3 billion in Q2 2026, $1.3 billion in Q1 2026, and -$2.7 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Alkermes | 8.07 Bn | 7.42 Bn | 397.90 Mn | 18.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.26 Bn |
| Mar 31, 2026 | 1.28 Bn |
| Dec 31, 2025 | -2.70 Bn |
| Sep 30, 2025 | 2.87 Bn |
| Jun 30, 2025 | 1.28 Bn |
| Mar 31, 2025 | 1.21 Bn |
| Dec 31, 2024 | -492.68 Mn |
| Sep 30, 2024 | 2.80 Bn |
| Jun 30, 2024 | 1.07 Bn |
| Mar 31, 2024 | 1.14 Bn |
| Dec 31, 2023 | 599.40 Mn |
| Sep 30, 2023 | 2.78 Bn |
| Jun 30, 2023 | 1.23 Bn |
| Mar 31, 2023 | 1.27 Bn |
| Dec 31, 2022 | 1.04 Bn |
| Sep 30, 2022 | 756.19 Mn |
| Jun 30, 2022 | 1.16 Bn |
| Mar 31, 2022 | 2.14 Bn |
| Dec 31, 2021 | 1.02 Bn |
| Sep 30, 2021 | 885.03 Mn |